Latest News
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
- KIMS Hospitals Introduces Adaptive Deep Brain Stimulation in India for Advanced Parkinson’s Treatment
R-Pharm group invests 4 billion rubles in production in St. Petersburg
R-Pharm intends to build drug manufacturing facilities in St. Petersburg under the first offset contract by 2026.
- By Newsdesk
- Russia
- Mar 03, 2023
According to the press service of the city's governor, AO R-Pharm (part of the R-Pharm group of companies) is investing more than 4 billion rubles in the construction of a pharmaceutical manufacturing plant in St. Petersburg.
Specifically, 2.9 billion rubles will be allocated for plant construction and equipment procurement, and 1.2 billion rubles will be allocated for R&D and technology deployment.
According to earlier reports, R-Pharm intends to build drug manufacturing facilities in St. Petersburg under the first offset contract by 2026. The city of St. Petersburg and R-Pharm signed a 10-year contract in January. The contract stipulates that the city authorities will purchase drugs from the company for a total of 8.7 billion rubles for seven years after the construction is completed.
The company is expected to manufacture 31 pharmaceutical products, including generics for the treatment of cancer, cardiovascular and neurological diseases, and diabetes as part of the project.